๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The clinical pharmacology of tolmesoxide

โœ Scribed by C. P. O'Boyle; M. Laher; E. T. O'Brien; K. O'Malley; J. G. Kelly


Publisher
Springer
Year
1982
Tongue
English
Weight
435 KB
Volume
23
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The clinical pharmacology of mitozantron
โœ John F. Smyth; Janet S. Macpherson; Pamela S. Warrington; Robert C. F. Leonard; ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer ๐ŸŒ English โš– 374 KB

The pharmacological disposition of the anthracenedione mitozantrone has been measured in 11 patients with six different tumour types. Administered at 14 mg/m2 as a 30-min infusion, the drug was assayed by a high-pressure liquid chromatographic technique sensitive to 1 ng mitozantrone/ml plasma. The

Clinical pharmacology of methotrexate
โœ Bertino, J. R. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 746 KB

## Abstract Methotrexate (MTX), a potent folate antagonist by virtue of its ability to inhibit the enzyme dihydrofolate reductase [1], continues to be a useful cancer chemotherapeutic agent [2]. Information not only on its mechanism of action, but also its pharmacology has led to improved dosage sc

Clinical pharmacology of carvedilol
โœ Tomlinson, B. ;Prichard, B.N.C. ;Graham, B.R. ;Walden, R.J. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 922 KB

Animal work has shown that carvedilol is a nonselective beta-blocking drug. It has a vasodilator action from alpha-receptor blockade, but there is evidence that it has further action to relax smooth muscle, possibly from calcium channel antagonism. Carvedilol is lipid soluble and 25% bioavailable, a